Send to a Friend Font Size: Increase Decrease

ESALF and BIIB Related Headlines

Jul 15, 2026 01:29PM FDA approves Leqembi Iqlik subcutaneous injection for Alzheimer's
Jan 25, 2026 11:52PM FDA accepts Eisai's LEQEMBI IQLIK application for priority review
Nov 26, 2025 06:03AM Eisai completes FDA submission for LEQEMBI subcutaneous starting dose

ESALF and BIIB Related Press Releases

ESALF and BIIB Related SEC Filings